Published in Brain Res on January 29, 1993
Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addict Biol (2010) 1.00
Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcohol Clin Exp Res (2007) 0.98
N-methyl-D-aspartate receptor subunit expression in adult and adolescent brain following chronic ethanol exposure. Neuroscience (2010) 0.93
The expression of NMDA receptor subunit mRNA in human chronic alcoholics. Ann N Y Acad Sci (2008) 0.91
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets (2010) 0.86
In vivo metabolite differences between the basal ganglia and cerebellum of the rat brain detected with proton MRS at 3T. Psychiatry Res (2007) 0.81
A novel alcohol-sensitive position in the N-methyl-D-aspartate receptor GluN2A subunit M3 domain regulates agonist affinity and ion channel gating. Mol Pharmacol (2013) 0.81
Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult. Curr Neuropharmacol (2014) 0.76
An in vitro model for studying the effects of continuous ethanol exposure on N-methyl-D-aspartate receptor function. Alcohol (2011) 0.76
Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists. Curr Neuropharmacol (2011) 0.75
Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60
Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med (1988) 1.31
Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Brain Res Mol Brain Res (1996) 1.23
Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol (1990) 1.22
Finding the gene(s) for alcoholism. JAMA (1990) 1.21
N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem (1989) 1.18
Alcohol tolerance. Ann Emerg Med (1986) 1.15
Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J Neurosci (1999) 1.15
Acute alcohol intoxication, mood states and alcohol metabolism in women and men. Pharmacol Biochem Behav (1983) 1.08
Selective effects of ethanol on the generation of cAMP by particular members of the adenylyl cyclase family. Alcohol Clin Exp Res (1995) 1.06
Purification and characterization of a reduced nicotinamide adenine dinucleotide phosphate-linked aldehyde reductase from brain. J Biol Chem (1970) 1.04
Animal models in alcohol research. Alcohol Res Health (2000) 1.03
Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res (1991) 1.01
A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem Biophys Res Commun (1993) 0.99
Alteration of striatal glutamate release after glutamine synthetase inhibition. J Neurochem (1984) 0.98
Ethanol and guanine nucleotide binding proteins: a selective interaction. FASEB J (1990) 0.97
Ethanol promotes apoptosis in cerebellar granule cells by inhibiting the trophic effect of NMDA. J Neurochem (1997) 0.97
Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol (1996) 0.96
Alcohol addiction: an enigma among us. Neuron (1996) 0.96
Human brain aldehyde reductases: relationship to succinic semialdehyde reductase and aldose reductase. J Neurochem (1980) 0.96
Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am J Med Genet (1993) 0.95
Corticosterone concentrations in mice during ethanol drinking and withdrawal. J Pharm Pharmacol (1978) 0.95
Brain acetaldehyde after ethanol administration. Biochem Pharmacol (1976) 0.94
An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier. Brain Res (1977) 0.94
Phosphorylation cascades control the actions of ethanol on cell cAMP signalling. J Biomed Sci (2001) 0.92
Adenylyl cyclases and alcohol. Adv Second Messenger Phosphoprotein Res (1998) 0.92
Ethanol and the NMDA receptor. Alcohol (1990) 0.91
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J Med Chem (1993) 0.91
Inhibition of binding of aldehydes of biogenic amines in tissues. Biochem Pharmacol (1973) 0.91
The role of the NMDA receptor in ethanol withdrawal. EXS (1994) 0.90
Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. Proc Natl Acad Sci U S A (1975) 0.90
Ethanol's actions on cAMP-mediated signaling in cells transfected with type VII adenylyl cyclase. Alcohol Clin Exp Res (1999) 0.89
Dose-response relationships in attenuation of puromycin-induced amnesia by neurohypophyseal peptides. Brain Res (1977) 0.88
Inhibition of a reduced nicotinamide adenine dinucleotide phosphate-linked aldehyde reductase from bovine brain by barbiturates. Mol Pharmacol (1971) 0.88
Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. Mol Pharmacol (1992) 0.88
Chronic ethanol exposure results in increased acute functional tolerance in selected lines of HAFT and LAFT mice. Psychopharmacology (Berl) (2001) 0.87
Involvement of protein kinase C in ethanol-induced inhibition of NMDA receptor function in cerebellar granule cells. Alcohol Clin Exp Res (1994) 0.87
Ethanol's effects on cortical adenylate cyclase activity. J Neurochem (1985) 0.87
Acute tolerance in inbred and selected lines of mice. Drug Alcohol Depend (1980) 0.86
Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine. Mol Pharmacol (2000) 0.86
Effect of ethanol on cyclic AMP levels in intact PC12 cells. Biochem Pharmacol (1990) 0.85
mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase. Mol Pharmacol (1996) 0.85
[AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism]. C R Seances Soc Biol Fil (1989) 0.85
Alcohol interactions with brain opiate receptors. Life Sci (1983) 0.85
Effect of an imidazobenzodiazepine, Ro15-4513, on the incoordination and hypothermia produced by ethanol and pentobarbital. Life Sci (1987) 0.85
Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brain. Mol Pharmacol (1990) 0.84
Attenuation of glutamate-induced neurotoxicity in chronically ethanol-exposed cerebellar granule cells by NMDA receptor antagonists and ganglioside GM1. Alcohol Clin Exp Res (1995) 0.84
Novel structure having antagonist actions at both the glycine site of the N-methyl-D-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization. J Pharmacol Exp Ther (2000) 0.84
Effects of chronic ethanol treatment on the beta-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J Neurochem (1987) 0.84
Activation of adenylate cyclase by alcohols requires the nucleotide-binding protein. J Pharmacol Exp Ther (1984) 0.84
Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor. Mol Pharmacol (1990) 0.84
Tolerance and the etiology of alcoholism: hypothesis and mechanism. Alcohol Clin Exp Res (1988) 0.84
Body temperature in mice: a quantitative measure of alcohol tolerance and physical dependence. J Pharmacol Exp Ther (1976) 0.84
Characterization of brain acetaldehyde oxidizing systems in the mouse. Drug Alcohol Depend (1980) 0.84
Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors. Mol Pharmacol (1987) 0.83
Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism. Alcohol Clin Exp Res (2000) 0.83
Separation of aldehyde reductases and alcohol dehydrogenase from brain by affinity chromatography: metabolism of succinic semialdehyde and ethanol. Biochem Biophys Res Commun (1975) 0.83
Selective inhibition by ethanol of glutamate-stimulated cyclic GMP production in primary cultures of cerebellar granule cells. Neuropharmacology (1989) 0.83
Inhibtion of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem (1975) 0.83
Effects of abstinence and family history for alcoholism on platelet adenylyl cyclase activity. Alcohol Clin Exp Res (1998) 0.82
Chronic ethanol exposure delays the 'developmental switch' of the NMDA receptor 2A and 2B subunits in cultured cerebellar granule neurons. J Neurochem (2001) 0.82
ADH and related peptides: effect of pre- or posttraining treatment on puromycin amnesia. Pharmacol Biochem Behav (1978) 0.82
Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther (1992) 0.82
Characterization of acute and chronic tolerance in mice selected for inherent differences in sensitivity to ethanol. Alcohol Clin Exp Res (1980) 0.82
The 5-HT3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin Exp Res (1994) 0.82
Human adenylyl cyclase type 7 contains polymorphic repeats in the 3' untranslated region: investigations of association with alcoholism. Am J Med Genet (1997) 0.81
Receptor-gated ion channels may be selective CNS targets for ethanol. Trends Pharmacol Sci (1991) 0.81
The influence of RNA and DNA template structures during transcript elongation by RNA polymerases. Biochem Biophys Res Commun (1995) 0.81
Chronic barbiturate treatment increases NMDA receptors but decreases kainate receptors in mouse cortex. Eur J Pharmacol (1993) 0.81
Antisense oligonucleotide to c-fos blocks the ability of arginine vasopressin to maintain ethanol tolerance. Eur J Pharmacol (1996) 0.81
Ethanol, sedative hypnotics, and glutamate receptor function in brain and cultured cells. Behav Genet (1993) 0.81
Enzymatic reduction of "biogenic" aldehydes in brain. Mol Pharmacol (1973) 0.81
Localization of the gene for a novel human adenylyl cyclase (ADCY7) to chromosome 16. Hum Genet (1995) 0.81
NMDA receptors: role in ethanol withdrawal seizures. Ann N Y Acad Sci (1992) 0.81
Hippocampal and cerebellar beta-adrenergic receptors and adenylate cyclase are differentially altered by chronic ethanol ingestion. J Neurochem (1989) 0.81
Opposite changes in turnover of noradrenaline and dopamine in the CNS of ethanol-dependent mice. Neuropharmacology (1990) 0.81
Chronic ethanol exposure attenuates the anti-apoptotic effect of NMDA in cerebellar granule neurons. J Neurochem (2000) 0.81
Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice. Psychopharmacology (Berl) (1983) 0.80